Pallas Capital Advisors LLC Ptc Therapeutics, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 4,203 shares of PTCT stock, worth $190,269. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,203
Previous 6,925
39.31%
Holding current value
$190,269
Previous $375,000
45.33%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding PTCT
# of Institutions
306Shares Held
80.6MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.85MShares$401 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$352 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.75MShares$351 Million5.81% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$246 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA4.69MShares$213 Million0.04% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.24B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...